Medium chain fatty acids for use in the prevention or treatment of cardiac enlargement and/or valvular heart disease
AssigneeSociete des Produits Nestle S.A.
InventorsQinghong Li, Maurice Beaumont
Life of this patent
Estimating the term…
Abstract
Medium chain fatty acids or a composition comprising medium chain fatty acids for use in the prevention or treatment of cardiac enlargement, valvular heart disease and/or a condition associated with either of the foregoing in a human.
Claims16
A method for the prevention or treatment of cardiac enlargement and/or valvular heart disease and/or a condition associated with either of the foregoing in a subject in need of same comprising administering to the subject a composition comprising medium chain fatty acids.
15-16. (canceled)
A composition comprising at least 5 wt % MCT, at least 0.3 wt % of DHA, at least 0.4% of EPA, at least 2 wt % of lysine, at least 2 wt % of methionine and cysteine combined, at least 0.15 wt % of magnesium, at least 0.9 IU/g of vitamin E, and at least 0.2% of taurine wherein, the MCT contains MCTs with more than 40% total C8 and more than 50% total C10.
Dependencies are inferred from the claim text.